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ABSTRACT Skeletal-type E-C coupling is thought to require a direct interaction between RyR1 and the a1S-DHPR. Most
available evidence suggests that the cytoplasmic II–III loop of the dihydropyridine receptor (DHPR) is the primary source of the
orthograde signal. However, identiﬁcation of the region(s) of RyR1 involved in bidirectional signaling with the a1S-DHPR
remains elusive. To identify these regions we have designed a series of chimeric RyR cDNAs in which different segments of
RyR1 were inserted into the corresponding region of RyR3 and expressed in dyspedic 1B5 myotubes. RyR3 provides
a preferable background than RyR2 for deﬁning domains essential for E-C coupling because it possesses less sequence
homology to RyR1 than the RyR2 backbone used in previous studies. Our data show that two regions of RyR1 (chimera Ch-10
aa 1681–2641 and Ch-9 aa 2642–3770), were independently able to restore skeletal-type E-C coupling to RyR3. These two
regions were further mapped and the critical RyR1 residues were 1924–2446 (Ch-21) and 2644–3223 (Ch-19). These results
both support and reﬁne the previous hypothesis that multiple domains of RyR1 combine to functionally interact with the DHPR
during E-C coupling.
INTRODUCTION
Unlike type-2 and type-3 ryanodine receptors (RyR2 and
RyR3, respectively) the type-1 isoform (RyR1) displays the
unique property of allowing excitation-contraction (E-C)
coupling in the absence of extracellular Ca21. This property
is referred to as skeletal-type E-C coupling. A mechanical
coupling model, in which there is a direct physical inter-
action between RyR1 and the a1S subunit of L-type Ca
21
channels (dihydropyridine receptor; a1S-DHPR) in the plas-
ma membrane, has been proposed to explain this phenom-
enon (Rios et al., 1993; Rios and Pizarro 1991; Schneider
1994). According to this model a depolarization-induced
conformational change in the DHPR, which acts as the sur-
face membrane voltage sensor, directly transmits a signal to
RyR1 causing its activation. The resulting calcium release
from the sarcoplasmic reticulum (SR) is essential for contrac-
tion (Berchtold et al., 2000).
Studies in dyspedic skeletal muscle myotubes that lack
expression of RyR1 have shown that there is also a
‘‘retrograde’’ signal from RyR1 to DHPR, which is respon-
sible for enhancement of the Ca21 channel activity of DHPR
(Nakai et al., 1996) in addition to the orthograde signal from
the DHPR to RyR1. This reciprocal bidirectional interaction
appears to be RyR1-speciﬁc, since native and expressed
RyR3 and expressed RyR2 lack the ability to enhance DHPR
activity (Nakai et al., 1997).
Extensive studies have been focused on the identiﬁcation
of the molecular domains of DHPR and RyR1 involved in
such bidirectional signaling. There is compelling evidence
suggesting that the putative cytoplasmic loop between the
intramembrane segments II and III (II–III loop) of the a1S
subunit of DHPR is both necessary and sufﬁcient for normal
E-C coupling. Its critical role was ﬁrst recognized by Tanabe
et al. (1990), who demonstrated the return of normal skeletal-
type E-C coupling in dysgenic myotubes expressing chimeric
cardiac DHPRs in which the cardiac II–III loop was replaced
with the skeletal-type sequence. Subsequent studies have
identiﬁed a 46-residue region of the skeletal II–III loop that
is sufﬁcient to both transfer strong skeletal-type E-C cou-
pling properties to an otherwise cardiac DHPR and remove
skeletal-type E-C coupling from an otherwise skeletal DHPR
(Grabner et al., 1999; Nakai et al., 1998b; Wilkens et al.,
2001). However, recent evidence indicates that other regions
of DHPR, in addition to a1S II–III loop, are able to interact
with RyRs and may contribute functional interactions in
signaling between DHPR and RyR1 (Leong and MacLennan
1998c; Slavik et al., 1997; Stange et al., 2001).
Whereas the studies of the region of the DHPR needed
to interact with RyR1 are numerous, studies aimed at
identifying the region(s) of RyR1 involved in cross talk
with DHPR during E-C coupling have only recently begun.
Studies of the crooked neck dwarf mutant chicken which
expresses only RyR3 (Airey et al., 1993a; Ivanenko et al.,
1995) and from dyspedic myotubes expressing RyR2 or
RyR3 (Fessenden et al., 2000; Nakai et al., 1997), have
shown that neither isoform could support skeletal-type E-C
coupling. Yamazawa et al. (1997) used cultured primary
myotubes from mice lacking expression of RyR1 and RyR3
to demonstrate that a mutated RyR1 in which the divergence
region D2 (amino acids 1342–1406 of RyR1) was deleted
could not restore skeletal-type E-C coupling. This suggested
that the D2 domain contributes structural determinants
important for E-C coupling in skeletal muscle.
Leong and MacLennan (1998a), using small RyR1 GST
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fusion proteins, identiﬁed a region of 37 amino acids, en-
compassing residues 1076–1112 of RyR1, that was able to
interact speciﬁcally with afﬁnity columns containing the
DHPR a1S II–III loop. Similarly, using afﬁnity chromatog-
raphy they reported that a GST fusion protein fragment
containing residues 922–1112 of RyR1 was also able to bind
to a column containing the DHPR a1S III–IV loop (Leong
and MacLennan, 1998c). In a more physiological approach,
Nakai et al. (1998a) used chimeric RyRs to express different
regions of RyR1 into an otherwise RyR2 receptor. He
reported that residues 1635–2636 of RyR1 were able to both
mediate skeletal-type E-C coupling and enhance DHPR
channel activity. They also found that a second chimera
containing the adjacent residues 2659–3720 was able to
enhance DHPR channel activity but displayed no skeletal-
type E-C coupling. These data suggest that at least two
independent regions of RyR1 might be involved in the cross
talk with DHPR. The fact that RyR1/RyR2 chimeras, which
are expressed in a RyR2 background that normally is not
present in skeletal muscle, were able to restored skeletal-
type E-C coupling suggests that the regions identiﬁed in this
study contain all the domain(s) of RyR1 required to support
the skeletal-speciﬁc protein-protein interactions during E-C
coupling. However, there is a body of evidence suggesting
that like in skeletal muscle, a direct or indirect interaction
may exist in cardiac muscle between RyR2 and a1C-DHPR
(Katoh et al., 2000; Mouton et al., 2001; Slavik et al., 1997).
Thus, it is possible that RyR2 may display a closer similarity
to RyR1 than was anticipated and therefore, the two proteins
may share several common functional domains. Some of
these domains may be critical for skeletal-type E-C coupling
and their ‘‘absence’’ would remain undetected in the RyR1/
RyR2 chimeras. In this regard, RyR3 seems to present less
homology to RyR1 than RyR2 (Ottini et al., 1996; Oyamada
et al., 1994), and no interaction between any DHPR and
RyR3 has been described so far. Additionally, unlike RyR2,
RyR3 is normally expressed in skeletal muscle. Together,
this suggests that RyR3 may be a better background than
RyR2 to identify speciﬁc regions of RyR1 critical for
skeletal E-C coupling in chimeric receptors.
To verify whether the critical domain of RyR1 previously
identiﬁed for Nakai et al. (1998a) is able to confer skeletal-
type E-C coupling regardless of the background in which
it is expressed, in this work we have generated a series
of chimeric RyR1/RyR3 receptors and expressed them in
dyspedic 1B5 myotubes which lack expression of all three
RyR isoforms. We report that exchanging residues 1681–
3770 of RyR1 for the corresponding residues from RyR3
allowed RyR3 to gain skeletal-type E-C coupling. Further-
more, we were able to dissect from this domain to two
separate smaller regions that were independently capable of
allowing RyR3 to gain skeletal-type E-C coupling. In-
terestingly, expression of this critical domain in an RyR3
background was less efﬁcient in restoring E-C coupling than
was previously reported in similar chimera in an RyR2
background (Nakai et al., 1998a). These data both conﬁrm
and reﬁne previous data reported with RyR1/RyR2 chimeras,
that these regions contain essential domains needed for E-C
coupling and suggest that multiple regions of RyR1 are in-
volved in its interaction with the DHPR during E-C coupling.
MATERIAL AND METHODS
Chimeric constructs
Amino acid alignments of RyR1 and RyR3 cDNAs sequences were
performed to select fragments of RyR1 to be inserted into the corresponding
sequence of RyR3. Speciﬁc primers were designed to amplify the selected
fragments by PCR using RyR1 as a template. Each set of primers inserted
a unique restriction site. Ampliﬁed fragments from RyR1 were inserted, in
frame, into the endogenous restriction site(s) of HSV-RyR3 plasmid as
follows (* indicates a created site, Sk: skeletal): Ch-10: BsiWI-HindIII (Sk
5045–7930); Ch-9 HindIII-AscI* (Sk 7930–11,311); Ch-17: BsiWI-KpnI
(Sk 5045–6652); Ch-18: KpnI-HindIII (Sk 6652–7930); Ch-19: HindIII-
XmaI (Sk 7930–9671); Ch-20: XmaI-AscI* (Sk 9671–11,311); and Ch-21:
StuI-BamHI (Sk 5771–7361). Chimeras Ch-4 (Sk 5045–11,311) and Ch-11
(Sk 6652–9671) were obtained by subcloning and ligation of chimeras Ch-
10 and Ch-9 or Ch-18 and Ch-19, respectively (Fig. 1). All chimeric
constructs were cloned into the HSV-1 amplicon vector pHSVprPUC (gift
of Dr. Howard Federoff, University of Rochester, Rochester, NY) and
packaged into HSV1 virions using a helper virus-free packaging system
(Fraefel et al., 1996; Wang et al., 2000).
Cell culture and infection
1B5 cells (RyR1, RyR2, and RyR3 null) were cultured on Matrigel (BD
Bioscience, San Jose, CA) coated 96-well plates (Costar, Corning, Acton,
MA) in DMEM 20% FBS, 100 mg/ml streptomycin sulfate, 100 u/ml
penicillin-G in 5% CO2. After reaching 60–70% conﬂuence cells were
allowed to differentiate into myotubes for four to ﬁve days by changing the
growth medium to DMEM containing 5% heat-inactivated horse serum-
FIGURE 1 Schematic representation of the structure of chimeric RyR1/
RyR3 receptor. The boxed areas indicate the regions of RyR3 replaced with
the corresponding portion of RyR1. Numbers refer to the amino acids of
RyR1 (R1) and RyR3 (R3) constituting each chimera. (A) Ch-4: R3(1-
1577)-R1(1681-3770)-R3(3620-4873); Ch-9: R3(1-2507)-R1(2642-3770)-
R3(3620-4873); Ch-10: R3(1-1577)-R1(1681-2641)-R3(2508-4873); Ch-
11: R3(1-2083)-R1(2218-3223)-R3(3089-4873). (B) Ch-17: R3(1-1577)-
R1(1681-2217)-R3(2083-4873); Ch-18: R3(1-2083)-R1(2218-2643)-
R3(2508-4873); Ch-19: R3(1-2507)-R1(2644-3223)-R3(3089-4873); Ch-
20: R3(1-3088)-R1(3224-3770)-R3(3620-4873); and Ch-21: R3(1-1797)-
R1(1924-2446)-R3(2618-4873). D3 depicts position of high divergence
sequence.
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100 mg/ml streptomycin sulfate, 100 u/ml penicillin-G in 23% CO2. Wells
containing differentiated myotubes were infected with 3 3 104 virion par-
ticles containing RyR1/RyR3 chimeric cDNAs for 2 h, and then cultured for
24–48 h before imaging.
Calcium imaging
Differentiated 1B5 myotubes were loaded with 5 mM Fluo-4AM (Molecular
Probes, Eugene, OR) at 378C, for 20 min in imaging buffer (125 mM NaCl,
5 mM KCl, 2 mM CaCl2, 1.2 mM MgSO4, 6 mM glucose, and 25 mM
HEPES, pH 7.4) supplemented with 0.05% BSA. Depolarization was
performed by perfusion with ﬁve to seven volumes of K1 buffer (50 mM
NaCl, 80 mM KCl, 2 mM CaCl2, 1.2 mM MgSO4, 6 mM glucose, and 25
mM HEPES, pH 7.4) using a Multivalve Perfusion System (Automate
Scientiﬁc, Oakland, CA). When appropriate, to make certain that the re-
sponses seen were the result of skeletal-type E-C coupling, the imaging and
K1 depolarization buffers were made nominally Ca21 free (;5 mM free
Ca21) and supplemented with 0.5 mM Cd21 and 0.1 mM La31 to prevent
possible Ca21 entry from the extracellular medium into the cells. Because of
difﬁculties removing Cd21 and La31 from the wells, all the experiments
were ﬁrst carried out in Ca21-containing medium and then in Ca21-free
medium plus Cd21 and La31. Imaging was performed at 496 nm and data
were collected at 30 fps with an intensiﬁed 12-bit digital intensiﬁed CCD
(Stanford Photonics, Stanford, CA) and the data analyzed using QED
Camera Plug-in package (QED Imaging, Pittsburgh, PA). A caffeine dose
response curve was performed to evaluate the function of all of the chimeric
constructs. Different caffeine concentrations were assayed in imaging buffer
in the presence of extracellular Ca21. Because of the fact that low caffeine
concentrations can induce brief Ca21 transients having peak amplitudes near
to those reached by higher caffeine concentration but a much smaller total
Ca21 release, we found that the average ﬂuorescence of the calcium transient
better represents the total Ca21 transient behavior. To compare different
experiments, individual average ﬂuorescence was normalized to the max-
imal ﬂuorescence obtained in the same cell (obtained by the addition of
5 mM or 20 mM caffeine for RyR3 and RyR1, respectively). To compare
the efﬁciency of the different chimeras in restoring E-C coupling the
normalized average ﬂuorescence of the KCl-induced Ca21 transient (Figs.
3 C and 4 C) was determined only in those cells in which E-C coupling was
restored. Data are presented as mean 6 SE calculated using Excel software
(Microsoft Ofﬁce 2001, Microsoft, Seattle WA). Differences among the data
were evaluated for statistical signiﬁcance using a one-way Kruchall-Wallace
ANOVA (nonparametric) analysis (GraphPad Software, San Diego, CA).
Membrane preparation and immunoblotting
Crude membrane preparations were made 36 h after infection from 1B5
myotubes that had been allowed to differentiate for ﬁve days and were then
transduced with different constructs. Myotubes were harvested in harvest
buffer (137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH
7.2, and 0.6 mM EDTA) from 10–15 100-mm plates and centrifuged for 10
min at 2503 g. The pellet was resuspended in buffer consisting of 250 mM
sucrose, 10 mM HEPES pH 7.4, supplemented with 1 mM EDTA, 10 mg/ml
leupeptin, 0.7 mg/ml pepstatin A, 5 mg/ml aprotinin, and 0.1 mM PMSF and
then homogenized using a Polytron cell disrupter (Brinkmann Instruments,
Westbury, NY). The whole cell homogenates were centrifuged for 20 min at
15003 g, and the supernatants were collected and recentrifuged for 60 min
at 100,0003 g at 48C. The membranes were ﬁnally resuspended in 250 mM
sucrose, 20 mM HEPES, pH 7.4, frozen in liquid N2, and stored at 808C.
SDS-polyacrylamide gel electrophoresis (Laemmli 1970) was performed on
proteins from the crude homogenates as described previously. Immunoblots
were incubated with monoclonal antibody 34C (Airey and Sutko, ISHB,
University of Iowa), which recognizes both RyR1 and RyR3, and then
incubated with horseradish-peroxidase-conjugated goat anti-mouse second-
ary antibody. Immunoreactive proteins were developed with SuperSignal
ultra chemoluminescent substrate (Pierce, Rockford, IL).
[3H]-Ryanodine binding assay
High afﬁnity binding of [3H]-ryanodine (56 Ci/mmol; New England
Nuclear, Boston, MA) to crude membrane extracts (0.05–0.15 mg/ml) was
performed in the presence of 1M KCl, 20 mM HEPES pH 7.4, and 5 nM
[3H]-ryanodine in the presence of 100 mM free Ca21. The binding reaction
was initiated by the addition of cell membranes to the medium and the
mixture was permitted to equilibrate at 378C for 3 h. Nonspeciﬁc binding
was assessed in the presence of 5 mM unlabeled ryanodine. Separation of
bound and free ligand was performed by rapid ﬁltration through Whatman
GF/B glass ﬁber ﬁlters using a Brandel cell harvester (Gaithersburg, MD).
Filters were washed with three volumes of 0.5 ml ice-cold wash buffer
containing 20 mM Tris-HCl, 1M KCl, and 100 mM CaCl2, pH 7.1, and
placed into vials with 5 ml scintillation cocktail (Ready Safe; Beckman
Instruments, Fullerton, CA). The [3H]-ryanodine remaining on the ﬁlters
was quantiﬁed by liquid scintillation spectrometry.
RESULTS
Previous studies using chimeric RyR1/RyR2 receptors have
identiﬁed two adjacent regions of RyR1, chimera R10 (RyR1
residues 1635–2636) and chimera R9 (RyR1 residues 2659–
3720), involved in mediating the reciprocal interaction
between RyR1 and DHPR (Nakai et al., 1998a). Whereas
chimera R10 was able to both mediate skeletal-type E-C
coupling and enhance Ca21 channel activity, R9 was only
able to enhance Ca21 channel function. Based on this ﬁnd-
ing, and to identify the regions of RyR1 responsible for sup-
porting skeletal-type E-C coupling, we designed different
cDNAs constructs encoding chimeric receptors, in which
selected regions of RyR1 were inserted in frame into the
corresponding sequence of RyR3.
Accordingly, we designed two series of chimeric recep-
tors. The ﬁrst series, chimeras Ch-4, Ch-9, Ch-10, and Ch-11
(Fig. 1 A), includes receptors containing RyR1 regions
formerly deﬁned as essential for the interaction of RyR1/
DHPR (namely R4, R9, and R10 in Nakai et al., 1998a). The
second series, chimeras Ch-17, Ch-18, Ch-19, Ch-20, and
Ch-21 (Fig. 1 B), was intended to further reﬁne the regions of
RyR1 directly involved in conferring on RyR1 the ability to
support skeletal-type E-C coupling.
Transient expression of chimeric RyR cDNAs
In earlier studies we have shown that 1B5 dyspedic cells
express all the key proteins needed for E-C coupling, but
they lack expression of both RyR1 and RyR3 (Moore et al.,
1998). Expression of the receptors in 1B5 myotubes was
achieved using roughly equivalent levels of HSV-1 virion
particles containing the chimeric cDNAs. Transient expres-
sion of the constructs was detected with monoclonal anti-
body 34C, which recognizes a conservative RyR epitope
(Airey et al., 1990; Tong et al., 1997) that allows comparable
identiﬁcation of all three RyR isoforms (Airey et al., 1993b).
Transduction of 1B5 dyspedic myotubes with virion parti-
cles containing wtRyR1, wtRyR3, or any of the chimeric
constructs led to a high percentage of myotubes expressing
RyR1 Domains Involved in E-C Coupling 2657
Biophysical Journal 84(4) 2655–2663
RyRs. Immunostaining using 34C antibody showed that 50–
60% of the transduced myotubes displayed a punctate pattern
of labeling (data not shown), previously shown as charac-
teristic of RyRs properly localized at peripheral junctions
(i.e., junctional SR/plasma membrane boundary, Protasi
et al., 2000).
The Western blot in Fig. 2 A shows that membrane
extracts from myotubes transduced with wtRyR1 or wtRyR3
expressed high molecular weight proteins, with RyR3 exhib-
iting a slightly higher mobility than RyR1 as has been
previously shown for both wt and recombinant proteins
(Chen et al., 1997; Fessenden et al., 2000; Murayama and
Ogawa, 1997). Consistently, each of the RyR1/RyR3 chi-
meras expressed a high molecular weight protein with no
evident differences in their molecular size as compared to
their wtRyR3 parent, indicating that the insertion of different
regions of RyR1 into the RyR3 sequence did not result in
apparent change in size of the chimeric receptors. Variations
in the level of expression of full-length RyR in any given
culture were observed. Cultures expressing wtRyR1 con-
sistently presented a lower level of expression than those
expressing wtRyR3 or the chimeric constructs. This was
further conﬁrmed by [3H]-ryanodine binding experiments
(see below). Similar ﬁndings have been seen in heterologous
cells expressing RyR2 and RyR3 (Du et al., 1998; Rossi
et al., 2002). Despite this we did not see any signiﬁcant
differences in the morphology of the expression pattern of
all constructs when we examined the cells using immunohis-
tochemistry. In addition, slight differences in the level of
the expression were also observed among the chimeric con-
structs (Fig. 2 A).
Caffeine dose response
Caffeine dose response curves were performed on Fluo
4-loaded cells to evaluate the functionality of the chimeric
proteins expressed in the 1B5 myotubes. To make certain
that any difference in the EC50 between constructs represents
an actual difference in the properties of the channels and not
the result of differential levels of expression, all EC50 values
for caffeine were calculated from three independent experi-
ments using three different cultures and at least two different
viral stocks to transduce the cells. Average calcium transient
ﬂuorescence (see Materials and Methods) was normalized to
the maximal response to caffeine (5 mM for RyR3 and
20 mM for RyR1).
In agreement with previous studies (Fessenden et al.,
2000) we found that myotubes expressing wtRyR3 and
wtRyR1 displayed different sensitivities to caffeine (Fig. 2
B), with RyR3 being more sensitive than RyR1. There was
a signiﬁcant difference in the caffeine EC50 between RyR1
and RyR3 (EC50 ¼ 3.92 mM versus 0.47 mM, respectively,
Table 1). Only small differences in the caffeine EC50 were
observed among chimeric receptors and like wtRyR3 all
chimeras had EC50 values below 1 mM. Statistical analysis
showed no signiﬁcant difference in caffeine EC50 (p[0.05)
between wtRyR3 and any of the chimeric constructs assayed.
However, all the chimeric constructs had a signiﬁcantly
lower EC50 for caffeine than wtRyR1 (p\ 0.05).
FIGURE 2 Structural/functional characterization of chimeric receptors.
(A) Western blot analysis of the proteins expressed by transduced myotubes.
10 mg/lane of protein were used for each of the samples, with the exception
of RyR1, which is 40 mg/lane. Numbers 1 and 3 represent wtRyR1 and
wtRyR3 respectively, and 4–21 the remaining chimeric receptors. Expressed
receptors were detected with mAb 34C. (B) Caffeine dose response of Fluo-4
loaded myotubes expressing wt- and chimeric receptors. Average ﬂuores-
cence (see Materials and Methods) represents the mean ﬂuorescence of 22–
69 cells from three independent experiments. Results are presented as
average 6 SE. EC50 values were obtained by ﬁtting the average data to
a statistical dose response equation (Prism, Graphpad Software).
TABLE 1 Density of speciﬁc [3H]-ryanodine-binding sites
(pmol/mg) and cellular responses to caffeine (EC50 ) for
1B5 myotubes expressing wt- and chimeric receptors
pmol [3H]-ryanodine bound/mg protein
Caffeine EC50
mMConstruct 6 SD n
wtRyR1 0.154* 6 0.012 6 3.92*
wtRyR3 0.853* 6 0.130 6 0.47*
Ch-4 1.414 6 0.313 6 0.34
Ch-9 0.849 6 0.062 3 0.58
Ch-10 0.734 6 0.063 3 0.47
Ch-11 1.841 6 0.123 3 0.78yz
Ch-17 0.565 6 0.057 6 0.63z
Ch-18 0.599 6 0.517 3 0.51z
Ch-19 1.523 6 0.075 3 0.32
Ch-20 1.277 6 0.056 3 0.58
Ch-21 1.823 6 0.347 6 0.39y
SD, standard deviation; n, number of independent determinations.
*p\ 0.001
yp\ 0.001
zp[ 0.05
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[3H]-Ryanodine binding to chimeric constructs
To further evaluate the functionality and the level of ex-
pression of the chimeric constructs we performed [3H]-rya-
nodine binding experiments. Speciﬁc [3H]-ryanodine binding
was assayed in vesicles from myotubes expressing wt-RyR1
and RyR3 and was compared to the binding to all chimeric
receptors. Table 1 shows maximal [3H]-ryanodine binding
in the presence of 1M KCl and 100 mM free Ca21. Under
these conditions wtRyR3 demonstrated speciﬁc binding
to ryanodine, ;5.5-fold higher than wtRyR1, a ﬁnding con-
sistent with the Western blot analysis showing that RyR3-
transduced myotubes always expressed a higher level of
receptor/mg total protein than RyR1-transduced myotubes.
This result is consistent with previous reports where similar
differences in [3H]-ryanodine binding have also been re-
ported for recombinant RyR1 and RyR3 expressed in HEK
cells (Rossi et al., 2002). Unlike RyR1/RyR2 chimeras, all
RyR1/RyR3 chimeric receptors showed high afﬁnity [3H]-
ryanodine binding, with a Bmax similar to wtRyR3 and 5- to
12-fold higher than wtRyR1 indicating a direct correlation
between the amount of receptor expressed and [3H]-ryano-
dine Bmax, observed.
Correlation of [3H]-ryanodine Bmax and
caffeine EC50
There was no relationship between [3H]-ryanodine Bmax and
caffeine EC50. Table 1 shows that constructs with equivalent
levels of [3H]-ryanodine Bmax can display signiﬁcant dif-
ferences in caffeine EC50 (i.e., chimeras Ch-21 and Ch-11)
conversely; constructs with up to threefold difference in their
average [3H]-ryanodine Bmax had the same caffeine EC50
(i.e., chimeras Ch-11, Ch-17, and Ch-18). Based on these
results it seems unlikely that the higher levels of expression
observed with RyR3 and all chimeras can account for the
increased caffeine sensitivity observed in these constructs
and that this decrease in EC50 is due to an intrinsic structural
difference somewhere in their common RyR3 backbone.
Restoration of E-C coupling by
chimeric receptors
Myotubes expressing wtRyR1 or wtRyR3 loaded with Fluo-
4AM were tested for their response to 80 mM KCl and 20 or
5 mM caffeine (Fig. 3) respectively. Upon application of KCl
for 5–10 s, robust intracellular Ca21 transients were ob-
served in 52/52 myotubes expressing RyR1 (n ¼ 3, inde-
pendent experiments), both in the presence and the absence
of extracellular Ca21. Unlike myotubes expressing wtRyR1,
in the presence of 2 mM Ca21, myotubes expressing
wtRyR3 responded to KCl depolarization either with a very
weak and slow increase in [Ca21]i or had no detectable
transient (Fig. 3 A). Only a few myotubes (16/40 myotubes,
[n¼ 3] Fig. 3 B) expressing RyR3 had a Ca21 transient with
an amplitude higher than 10% of the maximal Ca21 release
induced by 5 mM caffeine, and none showed a transient
which resembled the transients seen with RyR1 (Fig. 3, B
and C).
Although all myotubes expressing RyR3 were able to
respond to 5 mM caffeine in the presence of Cd21 and La31,
no depolarization-induced Ca21 transients were observed
under these conditions (0/40 myotubes assayed [n ¼ 3],
Fig. 3). This suggests that the small depolarization-induced
increase of [Ca21]i observed in the presence of 2 mM
extracellular Ca21 most likely represents sarcolemmal Ca21
inﬂux rather than Ca21 release from the SR. These results
also conﬁrm the fact that, unlike RyR1, RyR3 is not able to
FIGURE 3 Chimeric receptors Ch-4, Ch-9,
Ch-10, and Ch-11 support E-C coupling in
dyspedic myotubes. (A) Representative Ca21
transients in response to KCl and caffeine of
1B5 myotubes expressing wt- or chimeric
receptors. Cells were exposed to depolarization
with 80 mM KCl (black box) or 5–20 mM
caffeine (white box) for 5–10 s in the absence
and in the presence of 0.5 mM Cd21 and 0.1
mM La31. (B) Percentage of cells transduced
with wt- or chimeric receptors that respond to
depolarization. The number of cells was de-
termined either in the presence (gray bars) or
in the absence (black bars) of 2 mM Ca21 plus
Cd21 and La31 in the extracellular medium.
(C) Normalized peak ﬂuorescence of KCl-
induced Ca21 transients of wt- and chimeric
constructs, in the presence and in the absence
of [Ca21]o. These data represent the average
ﬂuorescence of only those cells that showed
a response to KCl in C. The horizontal bar
represents 10 s; the vertical bar represents 250
au of Fluo-4 ﬂuorescence.
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restore skeletal-type E-C coupling to dyspedic myotubes
(Airey et al., 1993a; Fessenden et al., 2000).
Fig. 3 A shows that the expression of chimera Ch-4 in
dyspedic myotubes led to the restoration of depolarization-
induced Ca21 transients, both in the presence (64/74 myo-
tubes, n ¼ 4) and absence (45/113 myotubes, n ¼ 5) of
extracellular Ca21. This ﬁnding is consistent with pre-
vious studies reporting that the sequence between amino
acid 1681–3770 of RyR1 contains the essential region
required to confer skeletal-type E-C coupling on RyR2
(Nakai et al., 1998a). Interestingly both the number of cells
responding (Fig. 3 B) and the magnitude of the Ca21
transients (Fig. 3, A and C) restored by Ch-4 in the absence
of extracellular Ca21 were always smaller than those ob-
served in the presence of 2 mM Ca21.
Like Ch-4, expression of chimeras containing smaller
segments of RyR1 such as Ch-10 (amino acid 1681–2641)
and Ch-9 (amino acid 2642–3770) were equally able to the
restore skeletal-type E-C coupling in dyspedic myotubes. In
the presence of Cd21 and La31 both of these chimeras had
a similar frequency of E-C coupling restoration (24/119
myotubes [n ¼ 7] and 14/57 myotubes [n ¼ 6], for Ch-10
and Ch-9 respectively) and both Ch-9 and Ch-10 had Ca21
transients of similar magnitude to each other and to Ch-4
(Fig. 3 C). Ch-11, which encompasses residues 2218–3223
of RyR1, was also able to restore E-C coupling in both the
presence (79/93 myotubes, n ¼ 5) and absence (48/133
myotubes, n ¼ 6) of extracellular Ca21. However the
kinetics of the Ca21 transient induced by depolarization in
the presence of Cd21 and La31 were always slower in Ch-
11-expressing cells than the kinetics of release in cells
expressing Ch-4, Ch-10, or Ch-9 (Fig. 3 A). Additionally,
Ca21 transients observed in Ch-11-expressing cells were
consistently smaller than those of the other chimeras in-
dicating a reduced ability to restore skeletal E-C coupling
(Fig. 3 C). Altogether, these data indicate that two adjacent
regions of RyR1 can independently engage skeletal-type E-C
coupling observed in chimera Ch-4.
To better deﬁne the essential sequences of RyR1 required
to confer skeletal-type E-C coupling to RyR1/RyR3 chi-
meras, we further divided chimera Ch-10 into two smaller
constructs, Ch-17 (RyR1: 1681–2217) and Ch-18 (RyR1:
2218–2643), and Ch-9 into chimeras Ch-19 (RyR1; 2644–
3223) and Ch-20 (RyR1; 3224–3770). Fig. 4, B and C show
that both chimera Ch-17 and Ch-18 were capable of restoring
E-C coupling in the presence of 2 mM extracellular Ca21,
where strong Ca21 transients were observed in 44/51
myotubes (n ¼ 3) expressing Ch-17 and 29/37 myotubes
(n ¼ 3) expressing Ch-18. However, the same cells failed to
display any E-C coupling in the absence of extracellular
Ca21 and presence of Cd21 and La31 (Fig. 4, A–C). Unlike
cells expressing Ch-17 and Ch-18, myotubes expressing
chimera Ch-19 retained their ability to restore E-C coupling
regardless of the presence of extracellular Ca21, where 15/71
myotubes assayed (n ¼ 3) were able to restore skeletal-type
E-C coupling in the presence of Cd21 and La31, the same
percentage of restoration that was accomplished by chimera
Ch-9. Chimera Ch-20 displayed only a weak restoration of
E-C coupling, even in the presence of extracellular Ca21
(Fig. 4, B and C), suggesting that chimera Ch-19 holds the
entire sequence responsible for the interaction with the
DHPR previously identiﬁed in Ch-9.
To evaluate whether a region containing parts of both
chimeras Ch-17 and Ch-18 was responsible for the activity
FIGURE 4 Chimeras Ch-19 and Ch-21 support skeletal-type E-C
coupling in dyspedic myotubes. (A) Representative calcium transients
induced by depolarization with 80 mM KCl (black box) and 5 mM caffeine
(white box) of dyspedic myotubes expressing chimeric receptors Ch-17, Ch-
18, Ch-19, Ch-20, and Ch-21. Fluorescent records represent only those
responses measured in the absence of extracellular Ca21 with added Cd21
and La31. (B) The percentage of cells transduced with chimeric receptors
that respond to depolarization. The number of cells was determined either in
the presence (gray bars) or in the absence (black bars) of 2 mM Ca21 plus
Cd21 and La31 in the extracellular medium. (C) Normalized peak ﬂuo-
rescence of KCl-induced Ca21 transients of chimeras Ch-4, Ch-17, Ch-18,
Ch-19, Ch-20, and Ch-21, in the presence and in the absence of [Ca21]o.
These data represent the average ﬂuorescence of only those cells that
showed a response to KCl in C. The horizontal bar represents 10 s; the verti-
cal bar represents 250 au of ﬂuorescence.
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displayed by chimera Ch-10, we designed chimera Ch-21-
encompassing residues 1924–2446 of RyR1. Fig. 4, B and C
show that 31/149 myotubes (n ¼ 5) expressing Ch-21 were
able to engage skeletal-type E-C coupling that was missed by
chimeras Ch-17 and Ch-18.
DISCUSSION
In previous reports, using chimeric RyR1/RyR2 ryanodine
receptors (Nakai et al., 1998a; Protasi et al., 2002) two
regions of RyR1 were identiﬁed that can independently
mediate the reciprocal interaction with skeletal DHPR. One
of these was more efﬁcient in restoring skeletal-type E-C
coupling and the other was more efﬁcient in stimulating the
a1S-DHPR to assemble in tetrads. Both were equally able to
enhance DHPR Ca21 current compared to dyspedic cells or
cells expressing RyR2. To validate these results in this work
we have expressed the same regions of RyR1 in a RyR3
background using a similar experimental approach. Expres-
sing chimeric RyR1/RyR3 ryanodine receptors in dyspedic
1B5 myotubes we have demonstrated that the regions of
RyR1 previously shown to restore skeletal-type E-C cou-
pling to RyR2 were also able to confer similar properties to
RyR3. This result supports the hypothesis that this central
domain contains at least part if not all of the critical regions
of RyR1 needed to provide skeletal-type E-C coupling, re-
gardless of the background in which it is expressed.
Converging on smaller domains within chimeras Ch-10
and Ch-9 we showed that chimera Ch-21 (amino acids 1924–
2446) and chimera Ch-19 (amino acids 2644–3223) are the
critical regions necessary to contribute all of the skeletal E-C
coupling function. Interestingly, these two domains neither
overlap nor are adjacent in the primary sequence, but are
separated from each other by 427 amino acids. Whether
these domains represent two independent topographic
regions of RyR1 that independently interact with the a1S-
DHPR, or they are conﬁgured into a single contiguous do-
main during protein folding, still remains to be resolved.
We found by Western blot analysis that, compared to
RyR1, there was an almost consistently increased level of
receptor expression in the RyR3-based constructs and that
this correlated with [3H]-ryanodine Bmax in all constructs.
Some of the cause for the difference in binding levels
between RyR1 and RyR3 constructs and differences in
binding among RyR3 chimeras is that different viral stocks
used to transduce the cells had different viral titers. This can
potentially lead to large differences in the number of cells
expressing any RyR in any culture and is the reason that
[3H]-ryanodine Bmax levels were not consistent among
membrane preparations from different cultures expressing
the same construct. The remainder of the difference in
expression levels can be attributed to the fact that levels of
RyR1 expression has been consistently been shown to be
lower than RyR2 and RyR3 when these constructs are
expressed in heterologous expression systems (Du et al.,
1998; Rossi et al., 2002). At ﬁrst glance it appears that this
difference in expression might be the cause of the increased
sensitivity to caffeine seen in cells expressing RyR3-based
constructs. This proved not to be the case. Using two
separate Ch-18 viral stocks, EC50 for caffeine was the same
in both; in their respective membrane preps, the ﬁrst prep
showed receptor expression levels and [3H]-ryanodine Bmax
similar to those of RyR1, whereas in the second receptor,
expression levels and [3H]-ryanodine Bmax were 10-fold
higher than RyR1. Our results are consistent with previous
ﬁndings that recombinant wtRyR1 and wtRyR3 expressed in
myotubes (Fessenden et al., 2000) and HEK293 cells (Rossi
et al., 2002) displayed similar differential caffeine sensitiv-
ities. Although it is still unknown what domain of the
receptor accounts for this difference, the fact that all of the
constructs expressing the highest caffeine sensitivity shared
common N-terminal and C-terminal regions make apparent
that the increased caffeine sensitivity must be determined by
one of these domains.
An intriguing result was the fact that in the presence of
2 mM Ca21 all chimeric receptors except Ch-20 presented
a near normal restoration of depolarization-induced E-C
coupling. Furthermore, unlike wtRyR1 the depolarization-
induced Ca21 transients in the presence of extracellular Ca21
were always stronger for all of the chimeras than in the
absence of the cation, indicating that Ca21 inﬂux through
the DHPR can make an important contribution to depolariza-
tion-induced Ca21 release signals. By comparison, RyR3-
expressing myotubes presented only a minimal level of
coupling and the amplitudes of the depolarization-induced
Ca21 transients, when present at all, were signiﬁcantly
smaller and displayed different kinetics than the depolariza-
tion-induced transients observed in cells expressing RyR1 or
any of the chimeric constructs except Ch-20. The most likely
explanation for the differences in the amplitude of the
depolarization-induced Ca21 transients in the presence of
extracellular Ca21 is that the RyR3 chimeras other than Ch-
20, unlike wtRyR3, are able to restore bidirectional signaling
with the DHPR and thus increase its current density similar
to the increase seen with RyR1/RyR2 chimeras (Nakai et al.,
1998a).
The ﬁnding that chimera Ch-17 (amino acids 1681–2217),
which contains the highly divergent D3 domain, was not able
to restore skeletal-type E-C coupling suggests that this
domain of RyR1 (amino acids 1872–1923) does not play an
essential role in E-C coupling. This is consistent with the
report of Proenza et al. (2002) who found that chimera R16
reverse, in which D3 domain of RyR1 was replaced with the
corresponding region of RyR2, retained a normal ability to
mediate bidirectional signaling during E-C coupling.
Furthermore, chimera R16 (RyR1 amino acids 1837–2154)
was only partially able to restore skeletal-type E-C coupling
when expressed in a RyR2 background (Proenza et al.,
2002). Despite the similarities in the function of RyR2 and
RyR3 chimeras there are signiﬁcant differences that must be
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explained. The most signiﬁcant difference we found was that
under identical experimental conditions as those described
in this study the RyR1/RyR2 chimeras containing RyR1
sequences within amino acids 1635–3720 (i.e., chimeras R4,
R10, and R9; Protasi et al., 2002) consistently showed a more
robust skeletal-type E-C coupling signal than their homol-
ogous chimeras (Ch-4, Ch-10, and Ch-9 respectively) in
a RyR3 background. It is possible that this decreased
efﬁciency of depolarization-induced response can be attrib-
uted simply to possible protein misfolding of any given
chimera. But, because there was basically no difference in
caffeine sensitivity, [3H]-ryanodine Bmax, or molecular size
of any of the chimeric RyR3 receptors compared with
wtRyR3, this strongly suggests that the substitution of RyR1
sequence in the different regions of these chimeric receptors
did not alter their overall protein conformation. Therefore the
differences observed between chimeras with RyR2 and
RyR3 backgrounds must come from the fact that the amino
acid sequences of RyR2 and RyR3 are not equivalent.
Although the overall amino acid sequence identity among
the RyRs subtypes is 67–70%, there are several regions
where the amino acid sequences signiﬁcantly diverge
(domains D1, D2, and D3). A close analysis of the sequence
in the proposed foot region reveals the existence of several
other short regions in which RyR1 shows a high homology
with RyR2 but very low homology with RyR3. It is likely
that some, or all, of these regions shared by RyR1 and RyR2
but not RyR3, represent domains that could either be critical
for E-C coupling or are needed to properly expose the critical
E-C coupling domains to the DHPR. In this regard,
particularly interesting is the highly divergent domain, D2
(RyR1 residues 1342–1403 and RyR2 1316–1400). This
region presents a very low homology between RyR1 and
RyR2 but the corresponding sequence in RyR3 is almost
completely absent. Yamazawa et al. (1997) have shown that
deletion of this region from RyR1 completely ablated
electrically-evoked Ca21 release in cultured myotubes
without affecting caffeine-induced Ca21 release, suggesting
that either this region plays a critical role in E-C coupling or
that the deletion of D2 region disrupts the structure of RyR1
sufﬁciently to prevent antegrade DHPR/RyR1 interaction.
Yamazawa also found that substitution of the D2 region of
RyR1 with the corresponding region of RyR2 could support
electrically evoked Ca21 release, suggesting an equivalence
of this domain between the type-1 and type-2 receptors. The
absence of this domain in our RyR1/RyR3 constructs may
very well at least partially explain the differences observed
between chimeras with RyR2 and RyR3 backgrounds, and in
some regards makes it surprising that any of the RyR3-based
chimeras showed any depolarization-induced Ca21 release at
all. A study of the role of D2 domain in the E-C coupling
restoration by chimeric RyR1/RyR3 receptors is currently on
going.
Previous attempts to ﬁnd region(s) of RyR1 involved in
interaction with the a1S-DHPR have led to the identiﬁcation
of RyR1 domains, which are both in the same or at different
locations in the primary sequence than those proposed by
Nakai et al. (1998a) or used in this study. Using a yeast two-
hybrid system, Proenza et al. (2002) reported that region
sR16 of RyR1 (residues 1837–2168) was able to interact
with DHPR a1S II–III loop (residues 720–765) but either
failed to restore or restored only weak skeletal-type E-C
coupling when it was expressed in an RyR2 background.
Using a protein afﬁnity chromatography approach, Leong
and MacLennan (1998a) have reported that a peptide
fragment containing amino acids 922–1112 of RyR1 was
able to bind skeletal but not cardiac II–III loop fused to GST.
Furthermore, the same domain also showed the ability to
bind III–IV loop from skeletal muscle (Leong and
MacLennan, 1998b,c). Although it has been shown that
only 46 amino acids in the a1S-DHPR II–III loop are
required to support skeletal E-C coupling (Grabner et al.,
1999) other in vitro studies have suggested that in addition to
the II–III loop, other regions of the a1S-DHPR and other
DHPR subunits may engage in physical contact with RyR1
(Beurg et al., 1997; Leong and MacLennan, 1998c; Mouton
et al., 2001; Strube et al., 1996). Taken altogether, the ac-
cumulated information supports the idea that several non-
contiguous domains of RyR1 are required to support normal
bidirectional interaction between RyR1 and DHPR during
the E-C coupling. The fact that these domains are broadly
spread into the primary sequence of RyR1 makes it some-
what unlikely that all of them come together to conﬁgure
a single interaction domain. However, until the three-dimen-
sional structure of both RyR1 and the entire triad complex is
determined at near-atomic resolution, it will be impossible to
determine the actual location of these domains.
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